Genetic forms of nephrogenic diabetes insipidus (NDI): Vasopressin receptor defect (X-linked) and aquaporin defect (autosomal recessive and dominant)

被引:50
作者
Bichet, Daniel G. [1 ,2 ,3 ]
Bockenhauer, Detlef [4 ]
机构
[1] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada
[2] Univ Montreal, Dept Mol & Integrat Physiol, Montreal, PQ H3C 3J7, Canada
[3] Hop Sacre Coeur, 5400 Boul Gouin Ouest, Montreal, PQ H4J 1C5, Canada
[4] Great Ormond St Hosp Children NHS Fdn Trust, UCL Inst Child Hlth, London, England
基金
加拿大健康研究院;
关键词
Nephrogenic diabetes insipidus; X-linked nephrogenic diabetes insipidus; Autosomal recessive nephrogenic diabetes insipidus; AVPR2; AQP2; Dehydration; Misfolded proteins; Cyclic AMP; WILD-TYPE AQUAPORIN-2; PROTEIN-COUPLED RECEPTORS; CELL-SURFACE EXPRESSION; WATER CHANNEL; PHARMACOLOGICAL CHAPERONES; AVPR2; MUTATIONS; V2; RECEPTOR; MUTANT; RESCUE; FAMILIES;
D O I
10.1016/j.beem.2016.02.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nephrogenic diabetes insipidus (NDI), which can be inherited or acquired, is characterized by an inability to concentrate urine despite normal or elevated plasma concentrations of the antidiuretic hormone, arginine vasopressin (AVP). Polyuria with hyposthenuria and polydipsia are the cardinal clinical manifestations of the disease. About 90% of patients with congenital NDI are males with X-linked NDI who have mutations in the vasopressin V2 receptor (AVPR2) gene encoding the vasopressin V2 receptor. In less than 10% of the families studied, congenital NDI has an autosomal recessive or autosomal dominant mode of inheritance with mutations in the aquaporin-2 (AQP2) gene. When studied in vitro, most AVPR2 and AQP2 mutations lead to proteins trapped in the endoplasmic reticulum and are unable to reach the plasma membrane. Prior knowledge of AVPR2 or AQP2 mutations in NDI families and perinatal mutation testing is of direct clinical value and can avert the physical and mental retardation associated with repeated episodes of dehydration. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:263 / 276
页数:14
相关论文
共 90 条
[1]  
Arthus MF, 2000, J AM SOC NEPHROL, V11, P1044, DOI 10.1681/ASN.V1161044
[2]  
Arthus MFLM, 2004, NDI FDN 2004 GLOB C
[3]   Vasopressin-V2 receptor stimulation reduces sodium excretion in healthy humans [J].
Bankir, L ;
Fernandes, S ;
Bardoux, P ;
Bouby, N ;
Bichet, DG .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (07) :1920-1928
[4]   Functional rescue of the constitutively internalized V2 vasopressin receptor mutant R137H by the pharmacological chaperone action of SR49059 [J].
Bernier, V ;
Lagacé, M ;
Lonergan, M ;
Arthus, MF ;
Bichet, DG ;
Bouvier, M .
MOLECULAR ENDOCRINOLOGY, 2004, 18 (08) :2074-2084
[5]   Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus [J].
Bernier, Virginie ;
Morello, Jean-Pierre ;
Zarruk, Alexandro ;
Debrand, Nicolas ;
Salahpour, Ali ;
Lonergan, Michle ;
Arthus, Marie-Francoise ;
Laperriere, Andre ;
Brouard, Remi ;
Bouvier, Michel ;
Bichet, Daniel G. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (01) :232-243
[6]  
Bichet D.G., 2001, The Metabolic and Molecular Bases of Inherited Disease, V3, P4181
[7]   EPINEPHRINE AND DDAVP ADMINISTRATION IN PATIENTS WITH CONGENITAL NEPHROGENIC DIABETES-INSIPIDUS - EVIDENCE FOR A PRE-CYCLIC AMP V2-RECEPTOR DEFECTIVE MECHANISM [J].
BICHET, DG ;
RAZI, M ;
ARTHUS, MF ;
LONERGAN, M ;
TITTLEY, P ;
SMILEY, RK ;
ROCK, G ;
HIRSCH, DJ .
KIDNEY INTERNATIONAL, 1989, 36 (05) :859-866
[8]   X-LINKED NEPHROGENIC DIABETES-INSIPIDUS MUTATIONS IN NORTH-AMERICA AND THE HOPEWELL HYPOTHESIS [J].
BICHET, DG ;
ARTHUS, MF ;
LONERGAN, M ;
HENDY, GN ;
PARADIS, AJ ;
FUJIWARA, TM ;
MORGAN, K ;
GREGORY, MC ;
ROSENTHAL, W ;
DIDWANIA, A ;
ANTARAMIAN, A ;
BIRNBAUMER, M .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (03) :1262-1268
[9]   HEMODYNAMIC AND COAGULATION RESPONSES TO 1-DESAMINO[8-D-ARGININE] VASOPRESSIN IN PATIENTS WITH CONGENITAL NEPHROGENIC DIABETES-INSIPIDUS [J].
BICHET, DG ;
RAZI, M ;
LONERGAN, M ;
ARTHUS, MF ;
PAPUKNA, V ;
KORTAS, C ;
BARJON, JN .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (14) :881-887
[10]  
BICHET DG, 1994, AM J HUM GENET, V55, P278